ICS-283: a system for targeted intravenous delivery of siRNA

Expert Opinion on Drug Delivery
Raymond M Schiffelers, Gert Storm

Abstract

ICS-283 was developed within Intradigm Corporation as a system that is designed for the systemic delivery of therapeutic small interfering (siRNA) to sites of pathological angiogenesis. The non-viral siRNA delivery system is based on synthetic nanoparticles, known as Targe (Intradigm Corporation), which functions as a broad-platform technology to deliver siRNA to specific target cells in diseased tissues. The system is constructed to incorporate different functionalities that address critical needs for successful nucleic acid delivery. The TargeTran synthetic vector is a self-assembling, layered nanoparticle that protects and targets siRNA to specific cell types in pathological tissues. At present, ICS-283 is the only antiangiogenic siRNA delivery system that is designed for intravenous administration to treat angiogenesis-driven diseases.

References

Jul 29, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·S J Bogdanowich-KnippT J Siahaan
Aug 14, 2002·Cancer Treatment Reviews·S L Yowell, S Blackwell
Aug 30, 2002·Biochemical and Biophysical Research Communications·Jean-Rémi BertrandClaude Malvy
Jan 8, 2003·Seminars in Oncology·Judah Folkman
Jan 29, 2003·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Sandeep VermaMichael Famulok
Mar 12, 2003·Trends in Biotechnology·Kenneth Lundstrom
Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Jun 5, 2003·Nature Reviews. Cancer·Gabriele Bergers, Laura E Benjamin
May 26, 2004·Biochemical Society Transactions·J Takagi
Jun 9, 2004·Current Opinion in Chemical Biology·Mike M Hann, Tudor I Oprea
Jul 23, 2004·Expert Opinion on Biological Therapy·M Ravi KumarShyam S Mohapatra
Nov 3, 2004·Nucleic Acids Research·Raymond M SchiffelersMartin C Woodle
Nov 16, 2004·The Journal of Gene Medicine·Akin AkincRobert Langer
Nov 24, 2004·Current Opinion in Chemical Biology·Muthiah Manoharan
Dec 8, 2004·Current Gene Therapy·Barbara DemeneixJean-Paul Behr
Dec 9, 2004·Expert Opinion on Therapeutic Targets·Anthony P OrthSumit K Chanda
Jan 22, 2005·Annual Review of Medicine·Shahid M NimjeeBruce A Sullenger
Mar 16, 2005·Molecular Biotechnology·Yiling HuEric B Kmiec
Mar 17, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Amy C YanAndrew D Ellington
Mar 18, 2005·Pharmaceutical Research·Minhyung Lee, Sung Wan Kim
May 21, 2005·The Journal of Gene Medicine·Stéphanie GrosseIsabelle Fajac
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·U LungwitzA Göpferich
Jun 21, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Joanna RejmanMassimo Conese
Jul 19, 2005·Critical Reviews in Eukaryotic Gene Expression·Yuji NakataAlan M Gewirtz
Jul 26, 2005·Biochemical and Biophysical Research Communications·Wen-Xuan YinChih-Chuan Liang
Aug 12, 2005·Journal of Biomolecular Screening·Tudor I OpreaLarry A Sklar
Aug 17, 2005·Current Drug Targets. Inflammation and Allergy·Zoltán Szekanecz, Alisa E Koch
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·H F Dvorak
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Roy S HerbstHerbert I Hurwitz
Sep 30, 2005·Drug News & Perspectives·G Romano
Oct 7, 2005·BioTechniques·Rachael L NeveWilliam A Carlezon
Oct 26, 2005·Advances in Genetics·Hai-Quan Mao, Kam W Leong
Oct 26, 2005·Biomaterials·Laura De LaporteLonnie D Shea
Nov 23, 2005·Oncology·Peter Carmeliet
Nov 23, 2005·Oncology·Napoleone Ferrara
Nov 25, 2005·Current Pharmaceutical Design·Oscar E SimonsonC I E Smith
Nov 29, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Kai TemmingRobbert J Kok
Nov 29, 2005·Advanced Drug Delivery Reviews·Christine DufèsAndreas G Schätzlein
Dec 13, 2005·Clinical Science·G Scott RalphNicholas D Mazarakis

❮ Previous
Next ❯

Citations

Apr 24, 2013·International Journal of Pharmaceutics·Gaoyang GuoBiliang Zhang
Jul 28, 2012·Therapeutic Delivery·Shaguna SethMichael V Templin
Nov 17, 2006·Expert Opinion on Investigational Drugs·Srdan VerstovsekAyalew Tefferi
Aug 18, 2012·Survey of Ophthalmology·Jin-Hong ChangDimitri T Azar
May 9, 2009·Advanced Drug Delivery Reviews·Yu-Kyoung Oh, Tae Gwan Park
Mar 20, 2015·Drug Delivery and Translational Research·James T Cole, Nolan B Holland
Apr 16, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·M WelsF Sauvage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.